首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1959619

血液採集市場成長機會、成長要素、產業趨勢分析及2026年至2035年預測。

Blood Collection Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: 2026年02月05日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球血液採集市場價值 108 億美元，預計到 2035 年將達到 195 億美元，年複合成長率為 6.2%。

全球疾病負擔日益加重、血液採集技術不斷進步以及全球醫療程序數量不斷增加，共同推動了血液採集市場的成長。隨著醫療系統越來越重視早期檢測、定期監測和精準醫療，對準確高效血液採集的需求持續上升。血液採集是診斷流程中的關鍵步驟，可支援疾病檢測、療效評估以及在多種醫療環境中對病患監測。臨床介入措施的增加進一步刺激了這項需求，需要在患者評估和復原過程中進行血液檢測。採集方法的進步、以安全為中心的設計以及簡化的工作流程也促進了血液採集技術的廣泛應用。這些因素共同推動了市場成長，同時也凸顯了可靠的血液採集解決方案在醫院、檢查室和照護現場場所的重要性。

市場範圍
開始年份	2025
預測年份	2026-2035
起始值	108億美元
預測金額	195億美元
複合年成長率	6.2%

預計到2025年，耗材市場規模將達82億美元。此細分市場包括用於血液樣本採集、處理和運輸的必需一次性產品。由於其一次性使用的特性，每次抽血後都需要這些產品，因此在整個醫療機構中都不可或缺。耗材在維持樣本完整性、防止污染和確保診斷結果準確性方面發揮著至關重要的作用。其廣泛且重複的使用持續推動臨床和檢查室對耗材的穩定需求。

預計到2025年，診斷業務將佔市場佔有率的50.7%。該業務涵蓋用於採集和分析血液樣本以進行疾病識別、監測和管理的設備和耗材。隨著常規體檢和慢性病管理需求的不斷成長，以及對高效先進的血液採集系統的日益依賴，該業務板塊正持續成長。

預計到2025年，北美血液採集市佔率將達到35.4%。該地區的成長主要得益於高診斷檢測量、完善的醫療基礎設施以及人口快速老化。老年人醫療保健需求的增加推高了對血液診斷工具的需求，進一步擴大了全部區域的市場規模。

生態系分析
影響產業的因素
- 促進因素
  - 慢性疾病和感染疾病的發生率增加
  - 血液採樣技術的進步
  - 手術數量增加
  - 人口老化加劇
- 產業潛在風險與挑戰
  - 輸血相關風險
  - 熟練醫療專業人員短缺
- 市場機遇
  - 政府主導的促進捐血和疾病篩檢的宣傳活動增加。
成長潛力分析
監管環境
- 北美洲
- 歐洲
科技趨勢
- 當前技術趨勢
- 新興技術
未來市場趨勢
差距分析
波特的分析
PESTEL 分析

第4章競爭情勢

介紹
企業市佔率分析
公司矩陣分析
主要市場公司的競爭分析
競爭定位矩陣
戰略儀錶板
主要進展
- 併購
- 合作夥伴關係和合資企業
- 新產品發布
- 擴張計劃

第5章市場估算與預測：依產品類型分類，2021-2034年

系統
- 自動化系統
- 手動系統
消耗品
- 靜脈注射用
  - 針頭和注射器
    - 雙頭針
    - 帶翅膀的採血套裝
    - 標準皮下注射針
    - 其他採血針
  - 採血管
    - 用於血清分離
    - EDTA
    - 肝素
    - 用於等離子體分離
  - 血袋
  - 其他靜脈產品
- 毛細管
  - 《採血針》
  - 微型容器管
  - 微量血球容積比管
  - 保溫裝置
  - 其他毛細血管產品

第6章市場估計與預測：依方法分類，2021-2034年

人工採血
自動化採血

第7章市場估計與預測：依應用領域分類，2021-2034年

診斷
治療
研究

第8章市場估算與預測：依最終用途分類，2021-2034年

醫院和診所
診斷中心
血庫
學術研究機構

第9章市場估計與預測：依地區分類，2021-2034年

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國

第10章：公司簡介

Abbott Laboratories
Becton, Dickinson, and Company
Cardinal Health
F. Hoffmann-La Roche
FL MEDICAL
Fresenius SE &Co
Greiner
Haemonetics Corporation
McKesson Corporation
Nipro Corporation
QIAGEN
Sarstedt AG &Co
Siemens Healthineers
Streck
Terumo Corporation
Thermo Fisher Scientific

簡介目錄

Product Code: 10597

The Global Blood Collection Market was valued at USD 10.8 billion in 2025 and is estimated to grow at a CAGR of 6.2% to reach USD 19.5 billion by 2035.

Growth is supported by the rising global disease burden, continuous progress in blood collection technologies, and the increasing volume of medical procedures performed worldwide. As healthcare systems place greater emphasis on early detection, routine monitoring, and precision-based treatment, the demand for accurate and efficient blood sampling continues to rise. Blood collection remains a foundational step in diagnostic workflows, supporting disease detection, therapy evaluation, and long-term patient monitoring across multiple care settings. The growing number of clinical interventions further reinforces demand, as blood-based assessments are required throughout patient evaluation and recovery processes. Advancements in collection methods, safety-focused designs, and workflow efficiency are also contributing to broader adoption. Together, these factors are strengthening market growth while reinforcing the importance of reliable blood collection solutions across hospitals, laboratories, and point-of-care environments.

Market Scope
Start Year	2025
Forecast Year	2026-2035
Start Value	$10.8 Billion
Forecast Value	$19.5 Billion
CAGR	6.2%

The consumables category generated USD 8.2 billion in 2025. This segment includes single-use products essential for collecting, handling, and transporting blood samples. Due to their disposable nature, these items are required for every blood draw, making them indispensable across healthcare facilities. Consumables play a critical role in maintaining sample integrity, preventing contamination, and ensuring accurate diagnostic outcomes. Their widespread and repetitive use continues to drive consistent demand across clinical and laboratory settings.

The diagnostics segment held 50.7% share in 2025. This segment encompasses devices and consumables used to collect and analyze blood samples for disease identification, monitoring, and management. Rising demand for routine testing and long-term condition management has increased reliance on efficient and advanced blood collection systems, supporting sustained growth in this segment.

North America Blood Collection Market accounted for 35.4% share in 2025. Regional growth is driven by high diagnostic testing volumes, well-established healthcare infrastructure, and a rapidly aging population. Increasing healthcare utilization among older individuals has led to higher demand for blood-based diagnostic tools, reinforcing market expansion across the region.

Key companies operating in the Global Blood Collection Market include Thermo Fisher Scientific, Becton, Dickinson, and Company, Abbott Laboratories, Siemens Healthineers, Cardinal Health, McKesson Corporation, Terumo Corporation, Greiner, Sarstedt AG & Co, Nipro Corporation, QIAGEN, Streck, Haemonetics Corporation, F. Hoffmann-La Roche, Fresenius SE & Co, and FL MEDICAL. Companies in the blood collection market are strengthening their market position through product innovation, safety enhancements, and expanded distribution networks. Manufacturers are investing in user-friendly, safety-engineered designs to reduce contamination risks and improve clinical efficiency. Emphasis on automation and compatibility with advanced diagnostic platforms helps streamline laboratory workflows. Strategic partnerships with healthcare providers and distributors support broader market reach. Firms are also expanding manufacturing capacity to meet rising global demand while ensuring regulatory compliance. Continuous focus on quality assurance, cost optimization, and sustainability initiatives further enhances competitiveness, allowing companies to maintain strong relationships with healthcare systems and reinforce long-term market presence.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Product trends
- 2.2.2 Method trends
- 2.2.3 Application trends
- 2.2.4 End use trends
- 2.2.5 Regional trends
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of chronic and infectious diseases
  - 3.2.1.2 Advancements in blood collection technologies
  - 3.2.1.3 Increasing number of surgical procedures
  - 3.2.1.4 Rising geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Risks associated with blood transfusions
  - 3.2.2.2 Lack of skilled healthcare professionals
- 3.2.3 Market opportunities
  - 3.2.3.1 Rising government-led campaigns for promoting blood donation and disease screening
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
3.5 Technology landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
4.7 Key developments
- 4.7.1 Mergers and acquisitions
- 4.7.2 Partnerships and collaborations
- 4.7.3 New product launches
- 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 System
- 5.2.1 Automated systems
- 5.2.2 Manual systems
5.3 Consumables
- 5.3.1 Venous
  - 5.3.1.1 Needles and syringes
    - 5.3.1.1.1 Double-ended needles
    - 5.3.1.1.2 Winged blood collection sets
    - 5.3.1.1.3 Standard hypodermic needles
    - 5.3.1.1.4 Other blood collection needles
  - 5.3.1.2 Blood collection tubes
    - 5.3.1.2.1 Serum-separating
    - 5.3.1.2.2 EDTA
    - 5.3.1.2.3 Heparin
    - 5.3.1.2.4 Plasma-separating
  - 5.3.1.3 Blood bags
  - 5.3.1.4 Other venous products
- 5.3.2 Capillary
  - 5.3.2.1 Lancets
  - 5.3.2.2 Micro-container tubes
  - 5.3.2.3 Micro-hematocrit tubes
  - 5.3.2.4 Warming devices
  - 5.3.2.5 Other capillary products

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Manual blood collection
6.3 Automated blood collection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 Diagnostics
7.3 Treatment
7.4 Research

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic centers
8.4 Blood banks
8.5 Academic and research institutes

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE